Characteristic |
N |
Fine & Gray model Univariate anemia_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.84 |
1.23, 2.77 |
0.003 |
Age |
434 |
1.01 |
1.00, 1.02 |
0.140 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.91 |
0.69, 1.20 |
0.490 |
baseline_cre_egfr |
434 |
0.99 |
0.98, 1.00 |
0.007 |
Characteristic |
N |
Fine & Gray Model Multivariate anemia_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.73 |
1.13, 2.65 |
0.011 |
Age |
434 |
1.00 |
0.98, 1.01 |
0.670 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.92 |
0.69, 1.22 |
0.570 |
baseline_cre_egfr |
434 |
0.99 |
0.98, 1.00 |
0.026 |
Characteristic |
N |
Fine & Gray model Univariate anemia_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.46 |
1.40, 4.34 |
0.002 |
Age |
434 |
1.01 |
0.99, 1.03 |
0.250 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.00 |
0.62, 1.62 |
>0.999 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.00 |
0.080 |
Characteristic |
N |
Fine & Gray Model Multivariate anemia_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.26 |
1.22, 4.19 |
0.010 |
Age |
434 |
1.00 |
0.97, 1.02 |
0.730 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.98 |
0.60, 1.61 |
0.950 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.01 |
0.210 |
Characteristic |
N |
Fine & Gray model Univariate throm_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.56 |
0.80, 3.07 |
0.190 |
Age |
434 |
1.01 |
0.99, 1.03 |
0.210 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.71 |
1.01, 2.89 |
0.044 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.00 |
0.066 |
Characteristic |
N |
Fine & Gray Model Multivariate throm_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.32 |
0.65, 2.70 |
0.440 |
Age |
434 |
1.00 |
0.98, 1.02 |
0.860 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.74 |
1.02, 2.97 |
0.044 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.00 |
0.110 |
Characteristic |
N |
Fine & Gray model Univariate throm_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
3.02 |
1.23, 7.42 |
0.016 |
Age |
434 |
1.02 |
0.99, 1.05 |
0.230 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
2.14 |
0.90, 5.08 |
0.085 |
baseline_cre_egfr |
434 |
0.99 |
0.97, 1.02 |
0.540 |
Characteristic |
N |
Fine & Gray Model Multivariate throm_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
2.73 |
1.01, 7.43 |
0.049 |
Age |
434 |
1.00 |
0.97, 1.04 |
0.790 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
2.06 |
0.85, 4.99 |
0.110 |
baseline_cre_egfr |
434 |
1.00 |
0.97, 1.03 |
0.870 |
Characteristic |
N |
Fine & Gray model Univariate aki_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.27 |
0.56, 2.87 |
0.560 |
Age |
434 |
1.01 |
0.99, 1.03 |
0.480 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.03 |
0.56, 1.90 |
0.930 |
baseline_cre_egfr |
434 |
1.01 |
0.99, 1.03 |
0.260 |
Characteristic |
N |
Fine & Gray Model Multivariate aki_2
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.30 |
0.56, 3.03 |
0.550 |
Age |
434 |
1.02 |
1.00, 1.05 |
0.090 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
0.96 |
0.52, 1.75 |
0.880 |
baseline_cre_egfr |
434 |
1.02 |
1.00, 1.05 |
0.100 |
Characteristic |
N |
Fine & Gray model Univariate aki_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
1.02 |
0.12, 8.54 |
0.990 |
Age |
434 |
1.04 |
0.98, 1.10 |
0.200 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.60 |
0.36, 7.12 |
0.540 |
baseline_cre_egfr |
434 |
1.02 |
0.97, 1.06 |
0.440 |
Characteristic |
N |
Fine & Gray Model Multivariate aki_3
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
0.82 |
0.08, 8.33 |
0.870 |
Age |
434 |
1.08 |
0.96, 1.20 |
0.190 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.36 |
0.35, 5.30 |
0.660 |
baseline_cre_egfr |
434 |
1.05 |
0.95, 1.15 |
0.340 |
Death only
Characteristic |
N |
**cox model Univariate death 365
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
7.58 |
4.21, 13.6 |
<0.001 |
Age |
434 |
1.03 |
1.01, 1.06 |
0.019 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.15 |
0.65, 2.05 |
0.635 |
baseline_cre_egfr |
434 |
1.00 |
0.98, 1.01 |
0.759 |
Characteristic |
**cox model multivariate death 365
|
HR |
95% CI |
p-value |
group_2 |
|
|
|
0 |
— |
— |
|
1 |
7.20 |
3.93, 13.2 |
<0.001 |
Age |
1.03 |
1.00, 1.06 |
0.068 |
Sex |
|
|
|
Female |
— |
— |
|
Male |
0.95 |
0.53, 1.71 |
0.875 |
baseline_cre_egfr |
1.01 |
1.00, 1.03 |
0.135 |
Characteristic |
N |
**cox model Univariate death 90
|
HR |
95% CI |
p-value |
group_2 |
434 |
|
|
|
0 |
|
— |
— |
|
1 |
|
11.4 |
4.50, 29.0 |
<0.001 |
Age |
434 |
1.03 |
0.99, 1.07 |
0.203 |
Sex |
434 |
|
|
|
Female |
|
— |
— |
|
Male |
|
1.32 |
0.54, 3.26 |
0.543 |
baseline_cre_egfr |
434 |
1.00 |
0.98, 1.03 |
0.786 |
Characteristic |
**cox model multivariate death 90
|
HR |
95% CI |
p-value |
group_2 |
|
|
|
0 |
— |
— |
|
1 |
12.2 |
4.58, 32.6 |
<0.001 |
Age |
1.01 |
0.97, 1.06 |
0.544 |
Sex |
|
|
|
Female |
— |
— |
|
Male |
1.06 |
0.42, 2.63 |
0.908 |
baseline_cre_egfr |
1.02 |
0.99, 1.05 |
0.157 |
KM curves

KM curves
